GL1X · GenesisL1 explorer

MolNFT v1 · #86456 · protein

The aeropath project and pseudomonas aeruginosa high-throughput crystallographic studies for assessment of potential targets in early stage drug discovery.

4B79 · Probable short-chain dehydrogenase: “The aeropath project and pseudomonas aeruginosa high-throughput crystallographic studies for assessment of…”. X-ray diffraction, 1 ligand (NAD), 7 pockets (best druggability 0.65). MolNFT v1…

PDB
4B79
Type
protein
Length
469 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Probable short-chain dehydrogenase
UniProt
Q9HWT0
Ligands
NAD
Pockets
7 · best druggability 0.65

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable short-chain dehydrogenaseprotein23646% helix, 17% strandQ9HWT0
BProbable short-chain dehydrogenaseprotein23347% helix, 18% strandQ9HWT0

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14600.650.7845NAD
23730.630.7838NAD
32250.550.7831empty
41570.420.7420empty
51060.360.7421empty

Interfaces

1 interface between chains.

  • A–B · 1729 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 4B79 · The aeropath project and pseudomonas aeruginosa high-throughput crystallographic studies… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.